Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,357 | -1,641 | -8,402 | -6,588 | -4,635 |
| Other Working Capital | -639 | -343 | -1,354 | -1,148 | -688 |
| Other Operating Activity | 663 | 329 | 1,898 | 1,424 | 949 |
| Operating Cash Flow | $-3,332 | $-1,655 | $-7,858 | $-6,312 | $-4,373 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -986 | -983 | 4,928 | 1,957 | 1,970 |
| Investing Cash Flow | $-986 | $-983 | $4,928 | $1,957 | $1,970 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,193 | 3,193 | 2,074 | 1,734 | 1,479 |
| Other Financing Activity | -21 | -11 | -47 | -42 | -33 |
| Financing Cash Flow | $3,172 | $3,182 | $2,027 | $1,693 | $1,446 |
| Exchange Rate Effect | 0 | -2 | -17 | -8 | -15 |
| Beginning Cash Position | 7,266 | 7,266 | 8,186 | 8,186 | 8,186 |
| End Cash Position | 6,120 | 7,808 | 7,266 | 5,515 | 7,215 |
| Net Cash Flow | $-1,146 | $542 | $-920 | $-2,671 | $-971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,332 | -1,655 | -7,858 | -6,312 | -4,373 |
| Free Cash Flow | -3,332 | -1,655 | -7,858 | -6,312 | -4,373 |